Arctic Bioscience AS (ABS.OL) Stock Price

Arctic Bioscience AS Price

CLOSED
2.67NOK-0.13 (-4.75 %)
Market closed

Over the last 5 years Arctic Bioscience AS grew revenue by 7.7% annually, reaching 43.48 M NOK. For Arctic Bioscience AS, the net margin of -110.2% is broadly stable versus -110.2% a few years ago. The consensus 12-month price target for Arctic Bioscience AS is 2.55 NOK, about 4.5% below where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Arctic Bioscience AS stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Arctic Bioscience AS over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Arctic Bioscience AS stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Arctic Bioscience AS's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Arctic Bioscience AS Stock Price History
DateArctic Bioscience AS Price
7/31/20262.67 NOK
7/30/20262.80 NOK
7/29/20262.80 NOK
7/28/20262.80 NOK
7/27/20262.80 NOK
7/24/20262.80 NOK
7/23/20262.80 NOK
7/22/20262.83 NOK
7/21/20262.86 NOK
7/20/20262.87 NOK
7/17/20263.00 NOK
7/16/20263.00 NOK
7/15/20263.00 NOK
7/14/20263.24 NOK
7/13/20263.25 NOK
7/10/20262.80 NOK
7/9/20263.25 NOK
7/8/20263.25 NOK
7/7/20262.85 NOK
7/6/20263.23 NOK
7/3/20263.14 NOK
7/2/20263.30 NOK
7/1/20263.30 NOK
6/30/20263.24 NOK
6/29/20263.30 NOK
6/26/20263.30 NOK
6/25/20263.35 NOK
6/24/20263.35 NOK
6/23/20263.15 NOK
6/22/20263.30 NOK
6/19/20263.30 NOK
6/18/20263.25 NOK
6/17/20263.01 NOK
6/16/20263.26 NOK
6/15/20263.29 NOK
6/12/20263.43 NOK
6/11/20263.43 NOK
6/10/20263.43 NOK
6/9/20263.43 NOK
6/8/20263.43 NOK
6/5/20263.43 NOK
6/4/20263.35 NOK
6/3/20263.18 NOK
6/2/20263.41 NOK
6/1/20263.20 NOK
5/29/20263.30 NOK
5/28/20263.10 NOK
5/27/20263.20 NOK
5/26/20263.36 NOK
5/22/20263.28 NOK
5/21/20263.32 NOK
5/20/20263.07 NOK
5/19/20263.13 NOK
5/18/20263.24 NOK
5/15/20263.04 NOK
5/13/20263.30 NOK
5/12/20263.00 NOK
5/11/20263.43 NOK
5/8/20263.44 NOK
5/7/20263.29 NOK
5/6/20263.29 NOK
5/5/20263.20 NOK
5/4/20263.30 NOK
4/30/20263.30 NOK
4/29/20263.45 NOK
4/28/20263.40 NOK
4/27/20263.46 NOK
4/24/20263.39 NOK
4/23/20263.45 NOK
4/22/20263.45 NOK
4/21/20263.37 NOK
4/20/20263.44 NOK
4/17/20263.46 NOK
4/16/20263.38 NOK
4/15/20263.12 NOK
4/14/20263.23 NOK
4/13/20263.24 NOK
4/10/20263.10 NOK
4/9/20263.42 NOK
4/8/20263.39 NOK
4/7/20263.44 NOK
4/1/20263.30 NOK
3/31/20263.30 NOK
3/30/20263.46 NOK
3/27/20263.24 NOK
3/26/20263.28 NOK
3/25/20263.23 NOK
3/24/20263.29 NOK
3/23/20263.14 NOK
3/20/20263.56 NOK
3/19/20263.10 NOK
3/18/20263.38 NOK
3/17/20263.38 NOK
3/16/20263.39 NOK
3/13/20263.40 NOK
3/12/20263.40 NOK
3/11/20263.40 NOK
3/9/20263.40 NOK
3/6/20263.40 NOK
3/4/20263.20 NOK
3/3/20263.45 NOK
3/2/20263.30 NOK
2/27/20263.30 NOK
2/26/20263.25 NOK
2/25/20263.42 NOK
2/24/20263.43 NOK
2/23/20263.20 NOK
2/20/20263.20 NOK
2/19/20263.11 NOK
2/18/20263.35 NOK
2/17/20263.35 NOK
2/16/20263.34 NOK
2/13/20263.38 NOK
2/12/20263.39 NOK
2/10/20263.47 NOK
2/9/20263.49 NOK
2/5/20263.45 NOK
2/4/20263.53 NOK
2/3/20263.30 NOK
2/2/20263.38 NOK
1/30/20263.45 NOK
1/29/20263.50 NOK
1/28/20263.49 NOK
1/27/20263.50 NOK
1/26/20263.50 NOK
1/23/20263.40 NOK
1/22/20263.41 NOK
1/21/20263.36 NOK
1/20/20263.37 NOK
1/19/20263.35 NOK
1/16/20263.29 NOK
1/15/20263.49 NOK
1/13/20263.55 NOK
1/12/20263.59 NOK
1/9/20263.47 NOK
1/8/20263.59 NOK
1/7/20263.50 NOK
1/6/20263.58 NOK
1/5/20263.59 NOK
1/2/20263.66 NOK
12/30/20253.28 NOK
12/29/20253.39 NOK
12/23/20253.24 NOK
12/22/20253.68 NOK
12/19/20253.30 NOK
12/18/20253.30 NOK
12/17/20253.64 NOK
12/16/20253.66 NOK
12/15/20253.51 NOK
12/12/20253.60 NOK
12/11/20253.40 NOK
12/10/20253.68 NOK
12/9/20253.80 NOK
12/8/20253.87 NOK
12/5/20253.87 NOK
12/4/20253.70 NOK
12/3/20253.68 NOK
12/2/20253.60 NOK
12/1/20253.80 NOK
11/28/20253.68 NOK
11/27/20253.71 NOK
11/26/20253.65 NOK
11/25/20253.65 NOK
11/24/20253.50 NOK
11/21/20253.44 NOK
11/20/20253.50 NOK
11/19/20253.30 NOK
11/18/20253.41 NOK
11/17/20253.72 NOK
11/14/20253.70 NOK
11/13/20253.70 NOK
11/12/20253.88 NOK
11/11/20253.84 NOK
11/10/20253.88 NOK
11/7/20253.79 NOK
11/6/20253.49 NOK
11/5/20253.58 NOK
11/4/20253.70 NOK
11/3/20253.35 NOK
10/31/20253.44 NOK
10/30/20253.53 NOK
10/29/20253.20 NOK
10/28/20253.32 NOK
10/27/20253.18 NOK
10/24/20253.68 NOK
10/23/20253.35 NOK
10/22/20253.50 NOK
10/21/20253.57 NOK
10/20/20253.39 NOK
10/17/20253.20 NOK
10/16/20253.10 NOK
10/15/20253.00 NOK
10/13/20253.18 NOK
10/10/20253.44 NOK
10/9/20253.27 NOK
10/8/20253.58 NOK
10/7/20253.30 NOK
10/6/20253.67 NOK
10/3/20253.68 NOK
10/2/20253.40 NOK
10/1/20253.30 NOK
9/30/20253.42 NOK
9/29/20253.34 NOK
9/26/20253.33 NOK
9/25/20253.40 NOK
9/24/20253.75 NOK
9/23/20253.55 NOK
9/22/20253.72 NOK
9/19/20253.69 NOK
9/18/20253.61 NOK
9/17/20253.95 NOK
9/16/20253.60 NOK
9/15/20254.03 NOK
9/12/20253.77 NOK
9/11/20254.15 NOK
9/10/20253.91 NOK
9/9/20254.15 NOK
9/8/20253.89 NOK
9/5/20253.97 NOK
9/4/20254.00 NOK
9/3/20253.57 NOK
9/2/20253.66 NOK
9/1/20253.85 NOK
8/29/20253.84 NOK
8/28/20254.10 NOK
8/27/20253.88 NOK
8/26/20254.11 NOK
8/25/20254.16 NOK
8/22/20253.94 NOK
8/21/20253.80 NOK
8/20/20253.98 NOK
8/19/20254.15 NOK
8/18/20254.20 NOK
8/15/20253.29 NOK
8/14/20253.50 NOK
8/13/20253.48 NOK
8/12/20253.40 NOK
8/11/20253.65 NOK
8/8/20253.67 NOK
8/7/20253.67 NOK
8/6/20253.72 NOK
Access this data via the Eulerpool API
Get Free API Key

Arctic Bioscience AS Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
30.04 M NOK
-3.08 M NOK
-3.99 M NOK
Jan 1, 2020
20.50 M NOK
-20.71 M NOK
-22.59 M NOK
Jan 1, 2021
21.52 M NOK
-38.46 M NOK
-42.58 M NOK
Jan 1, 2022
34.27 M NOK
-34.61 M NOK
-34.02 M NOK
Jan 1, 2023
33.75 M NOK
-48.59 M NOK
-45.51 M NOK
Jan 1, 2024
43.48 M NOK
-47.79 M NOK
-47.93 M NOK
Jan 1, 2025 (e)
103.02 M NOK
-4.04 M NOK
41.93 M NOK
Jan 1, 2026 (e)
65.65 M NOK
-15.66 M NOK
-70.52 M NOK

Arctic Bioscience AS Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 5:57 AM
 
REVENUEM NOK
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM NOK
EBITM NOK
EBIT MARGIN%
NET INCOMEM NOK
NET INCOME GROWTH%
SHARESM
2019202020212022202320242025e2026e
30.0020.0021.0034.0033.0043.00103.0065.00
–-33.335.0061.90-2.9430.30139.53-36.89
40.0025.0023.8132.3527.2725.5825.5825.58
12.005.005.0011.009.0011.0026.3516.63
-3.00-20.00-38.00-34.00-48.00-47.00-4.00-15.00
-10.00-100.00-180.95-100.00-145.45-109.30-3.88-23.08
-3.00-22.00-42.00-34.00-45.00-47.0041.00-70.00
–633.3390.91-19.0532.354.44-187.23-270.73
24.3024.3024.3024.3825.3725.3725.3725.37
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Arctic Bioscience AS generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Arctic Bioscience AS retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Arctic Bioscience AS's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Arctic Bioscience AS has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Arctic Bioscience AS's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Arctic Bioscience AS stock margins

The Arctic Bioscience AS margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Arctic Bioscience AS. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Arctic Bioscience AS.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
40.73 %
-10.26 %
-13.28 %
Jan 1, 2020
25.93 %
-101.03 %
-110.21 %
Jan 1, 2021
23.98 %
-178.77 %
-197.91 %
Jan 1, 2022
33.98 %
-101.00 %
-99.28 %
Jan 1, 2023
28.96 %
-143.96 %
-134.86 %
Jan 1, 2024
27.34 %
-109.90 %
-110.23 %
Jan 1, 2025 (e)
27.34 %
-3.92 %
40.70 %
Jan 1, 2026 (e)
27.34 %
-23.85 %
-107.43 %

Arctic Bioscience AS Stock Revenue, EBIT, Earnings per Share

The Arctic Bioscience AS earnings per share therefore indicates how much revenue Arctic Bioscience AS has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
1.24 NOK
-0.13 NOK
-0.16 NOK
Jan 1, 2020
0.84 NOK
-0.85 NOK
-0.93 NOK
Jan 1, 2021
0.89 NOK
-1.58 NOK
-1.75 NOK
Jan 1, 2022
1.41 NOK
-1.42 NOK
-1.40 NOK
Jan 1, 2023
1.33 NOK
-1.92 NOK
-1.79 NOK
Jan 1, 2024
1.71 NOK
-1.88 NOK
-1.89 NOK
Jan 1, 2025 (e)
3.82 NOK
-0.16 NOK
1.56 NOK
Jan 1, 2026 (e)
2.44 NOK
-0.62 NOK
-2.62 NOK

Arctic Bioscience AS business model & stock analysis

Arctic Bioscience AS Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Arctic Bioscience AS historical P/E ratio, EBIT multiple, and P/S ratio

Arctic Bioscience AS annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Arctic Bioscience AS shares outstanding

The number of shares of Arctic Bioscience AS was 25.37 M in 2025. This indicates how many shares Arctic Bioscience AS is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
24.30 M Stocks
Jan 1, 2020
24.30 M Stocks
Jan 1, 2021
24.30 M Stocks
Jan 1, 2022
24.38 M Stocks
Jan 1, 2023
25.37 M Stocks
Jan 1, 2024
25.37 M Stocks
Jan 1, 2025 (e)
25.37 M Stocks
Jan 1, 2026 (e)
25.37 M Stocks

Current Arctic Bioscience AS forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
0.00 % (0)
Hold
42.86 % (3)
Sell
57.14 % (4)
12M Price Target
2.55
Last Price
2.56
Currency
NOK
12M Return Potential
-0.39 %
LTM Return
0 %

Arctic Bioscience AS shareholder structure

% Name
11.45400%
Ronja Capital Investment AS
Ronja Capital Investment AS
5.72867%
Capra Invest AS
Capra Invest AS
4.87374%
MØRE OG ROMSDAL SÅKORNFOND AS
MØRE OG ROMSDAL SÅKORNFOND AS
3.85863%
Vartdal Holding AS
Vartdal Holding AS
2.98072%
Brødrene Vartdal AS
Brødrene Vartdal AS
2.47526%
Kotler Equity Investment Limited
Kotler Equity Investment Limited

Arctic Bioscience AS Executives and Management Board

13 members · avg. age 54 · 8 % women

Management

CV

Mr. Christer Valderhaug

Chief Executive Officer

–
JS

Mr. Jone Slinning

Chief Financial Officer

–
PS

Per Saebo

Chief Operating Officer

–
DM

Daniele Mancinelli

Chief Technology Officer

–
AB

Anders Blindheim

Chief Marketing Officer

–

Board of Directors

HN

Harald Nordal

Chairman of the Board

–
HC

Mr. Hu Cao

Director

–
PE

Mr. Per Eggesbo (60)

Director

–
MH

Ms. Marita Holstad

Director

–
AS

Mr. Asbjorn Solvagseide (63)

Director

–
TT

Mr. Tore Tonseth (43)

Director

–

Frequently asked questions about Arctic Bioscience AS

Analysts currently set an average price target of 2.55 NOK for the Arctic Bioscience AS stock (median: 2.55 NOK), implying -0.4 % versus the latest price. The consensus is based on 7 analyst ratings.

Arctic Bioscience AS Analyst Price Targets 2026

7 analysts currently rate the Arctic Bioscience AS stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Arctic Bioscience AS to generate revenue of 65.65 M NOK and earnings per share of -2.78 NOK.

Arctic Bioscience AS Analyst Price Targets 2026

Converted at the current exchange rate, the Arctic Bioscience AS share trades at 0.24 EUR (2.67 NOK).

No history available for Arctic Bioscience AS.

The expected revenue of Arctic Bioscience AS is 65.65 M NOK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Arctic Bioscience AS is -70.52 M NOK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Arctic Bioscience AS is currently -0.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Arctic Bioscience AS stock.

The price-to-sales ratio (P/S) of Arctic Bioscience AS is currently 1.03. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Arctic Bioscience AS stock.

The Eulerpool Quality Score for Arctic Bioscience AS is 3/10.

The ISIN of Arctic Bioscience AS is NO0010859580. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Arctic Bioscience AS is A2QP0Z. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Arctic Bioscience AS is ABS.OL. The ticker symbol is used to trade Arctic Bioscience AS shares on the stock exchange.

Arctic Bioscience AS paid dividends every year for the past 0 years.

Arctic Bioscience AS is assigned to the 'Health' sector.

The dividends of Arctic Bioscience AS are distributed in NOK.

All fundamentals and in-depth analysis of Arctic Bioscience AS

Our stock analysis for Arctic Bioscience AS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arctic Bioscience AS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Arctic Bioscience AS Stock
Arctic Bioscience AS Revenue→
Arctic Bioscience AS Stock
Arctic Bioscience AS Net Income→
Arctic Bioscience AS Stock
Arctic Bioscience AS P/E→
Arctic Bioscience AS Stock
Arctic Bioscience AS P/S→
Arctic Bioscience AS Stock
Arctic Bioscience AS EBIT→
Arctic Bioscience AS Stock
Arctic Bioscience AS Dividend→
Arctic Bioscience AS Stock
Arctic Bioscience AS Directors Dealings→
Arctic Bioscience AS Stock
Arctic Bioscience AS Stocks→
Arctic Bioscience AS Stock
Arctic Bioscience AS Market capitalization→
Arctic Bioscience AS Stock
Arctic Bioscience AS Debt→
Arctic Bioscience AS Stock
Arctic Bioscience AS Liabilities→
Arctic Bioscience AS Stock
Arctic Bioscience AS Equity→
Arctic Bioscience AS Stock
Arctic Bioscience AS AAQS→
Arctic Bioscience AS Stock
Arctic Bioscience AS Employees→
Arctic Bioscience AS Stock
Arctic Bioscience AS ROE→
Arctic Bioscience AS Stock
Arctic Bioscience AS ROA→
Arctic Bioscience AS Stock
Arctic Bioscience AS ROCE→
Arctic Bioscience AS Stock
Arctic Bioscience AS News→
Arctic Bioscience AS Stock
Arctic Bioscience AS Analyst Price Targets→

Health Stocks

Arcticzymes Technologies AArcomaArcturus Therapeutics HoldingsArch BiopartnersArcus BiosciencesArbutus BiopharmaArcutis BiotherapeuticsArabian International Healthcare Holding Company SJSCArdelyxArab Drug Company for Pharmaceuticals and Chemical Industries SAEArdent HealthAquestive TherapeuticsAll Stocks A–Z →